Global Epilepsy Drugs Market Analysis by Region and Future Trends till 2021

Epilepsy Drugs Market Size, Share and Forecast:

Epilepsy Drugs Market is likely to reach nearly USD 5.5 Billion by the year end of 2021.

Market growth can be attributed to factors such as rising incidence of neurological disorders, growing disease awareness, introduction of novel antiepileptic drugs AEDs , strong government support and initiatives. Moreover, increasing R&D investment and launch of extended-release formulations are further expected to fuel the market growth. However, high cost of patented drugs, concerns over decreasing healthcare costs as part of government austerity measures, particularly in Europe and low accessibility to antiepileptic drugs in low and middle income countries, are likely to restrict the market growth.

Vimpat is the undisputed leading drug of Global Epilepsy Drugs Market. It has a market share of nearly 22% in 2016 and is expected that Vimpat will gain its momentum till the forecasting period. Keppra was the second highest market share taker with more than 19% share in 2016 but the prospect of this drug will change due to the patent expiration in 2018 and its share decline to XX% by 2021. It is expected that Lamictal will be second leading drug with nearly XX% share by 2021. Onfi hold the third highest share of the Epilepsy Drugs market, being followed by Depakine by the year end of 2021.

The research report titled “Epilepsy Drugs Market: Global Demand, Growth Potential & Opportunity Outlook 2021” examines the market, competitive landscape and trends of the Global Epilepsy Drug Market. This report analyzes market data and provides a better understanding of Epilepsy Drugs sales value and demand in the Global Market. Market outlook in value terms for the forecasted period for Epilepsy Drugs Market has been detailed in the report.

Access Full Report with TOC @ https://www.planetmarketreports.com/reports/epilepsy-drugs-market-5175

Key trends in terms of collaborations, partnerships and licensing agreements are analysed with details. The report also explores detailed description of growth drivers and inhibitors of the Global Epilpesy Drugs Market.

The report concludes with the profiles of major players in the Epilepsy Drugs Market such as UCB, EISAI, Pfizer, Sanofi and Lundbeck. The major market players are evaluated on various parameters such as company overview and latest development and trends in the Epilepsy Drugs Market

Key Topics Covered in the Report

• Worldwide Epilepsy Drugs Market Analysis 2013 – 2021
• Worldwide Epilepsy Drugs Market Share 2013 – 2021
• Worldwide Epilepsy Drugs Brand Market Performance 2013 – 2021
• Epilepsy Drugs Market – Major Deal Types
• Key Companies Analysis
• Key Drivers and Inhibitors of the Epilepsy Drugs Market

Key Epilepsy Drugs Covered in the Report are as follows:

1. Vimpat Lacosamide
2. Keppra Levetiracetam
3. Briviact Brivaracetam
4. Lamictal Lamotrigine
5. Neurontin Gabapentin
6. Depakine Sodium Valproate
7. Sabril Vigabatrin
8. Onfi Clobazam
9. Fycompa Perampanel
10. Inovelon/Banzel Rufinamide
11. Zonegran Zonisamide
12. Zebinix Eslicarbazepine Acetate

Key Companies Covered in the Report are as follows:

1. UCB
2. EISAI
3. Pfizer
4. Sanofi
5. Lundbeck

Customizations available

In case of any queries or customization requirements please connect with our sales team sales@planetmarketreports.com, which will ensure that your requirements are met.

Browse a Free Sample Report @ https://www.planetmarketreports.com/report-sample/epilepsy-drugs-market-5175

About Us:

Planet Market Reports gives statistical surveying reports to businesses, people and associations with a goal of helping them in their decision making process. We have huge database of market research reports & company profiles across globe.  We associated with global market research a publisher who has a wide range of research specialists & industry experts which provides you deeper penetration of market research industry.

We have statistical surveying reports from number of top publishers and update our reports collections on daily basis with most recent research data to furnish our customers with the moment online access to our database. With access to this database, our customers will be able to benefit from expert insights on worldwide businesses, items, and market patterns. We help you in your buy choice by mapping your data needs with our immense accumulation of reports.

Contact US:- 

Name: Jennifer Daniel

Email-Id: sales@planetmarketreports.com

US: +1-716-2260907

UK: +447441952057

Organization: Planet Market Reports